Groove Botanicals Posts $104,420 Net Loss in Nine Months Ending December 2025

Groove Botanicals, a Nevada-incorporated company, reported a net loss of $104,420 for the nine months ending December 31, 2025, compared to a loss of $99,404 in the same period a year earlier. The company reported no revenue for either period. Read more earnings reports.

Operating expenses climbed to $104,420 for the nine-month period, up from $99,404 in the prior year. For the three months ending December 31, 2025, the net loss totaled $33,867, compared to $33,031 in the same quarter of 2024.

Selling, general, and administrative expenses declined slightly to $51,523 for the nine months ending December 2025, down from $52,187 in the prior-year period. For the December quarter alone, SG&A expenses fell to $16,041 from $17,255 a year earlier.

Balance Sheet and Cash Position

Total assets stood at $6,260 as of December 31, 2025, up from $4,520 at the end of March 2025. Cash and cash equivalents declined to $1,494 from $2,042 over the same period.

Total liabilities increased to $1.38 million as of December 31, 2025, compared to $1.11 million nine months earlier. The company's stockholders' deficit deepened to negative $1.38 million from negative $1.11 million as of March 31, 2025.

The accumulated deficit reached $35.46 million as of December 31, 2025, compared to $35.20 million at the start of fiscal 2026. The company has 59.64 million shares outstanding.

Cash Flow

Cash used in operations totaled $75,675 for the nine months ending December 2025, an improvement from $89,329 used in the prior-year period. Cash from financing activities provided $75,127 during the nine-month period, nearly offsetting the operational cash burn.